NOVADISCOVERY, a pioneer in in silico clinical trials, today announced the strengthening of its team with the nomination of its new Chief Scientific Officer, David duVerle, and the appointment of Prof. Marc Hommel as VP of Medicine.
In the presence of Mme Françoise Grossetête, Member of the European Parliament & Dr Adriano Henney, Secretary General of Avicenna Alliance.
The Avicenna Alliance has claimed a major victory in the revised EMA Regulation with the introduction of new text supporting modeling and simulation and predictive medicine in medicinal product development
The Avicenna Alliance, which Nova is a founding member of, releases its roadmap “in silico Clinical Trials: How Computer Simulation will Transform the Biomedical Industry”. This roadmap has been approved by the European Commission.
Novadiscovery secures an H2020 research grant for the RESSTORE project aimed at the clinical evaluation of a cell-based regenerative therapy in acute ischemic stroke